Full text
PDF







Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brogan E., Kozonis M. C., Overy D. C. Glucagon therapy in heart-failure. Lancet. 1969 Mar 8;1(7593):482–484. doi: 10.1016/s0140-6736(69)91587-6. [DOI] [PubMed] [Google Scholar]
- Condon J. R., Knight M. J., Day J. Intravenous glucagon. Br Med J. 1972 Feb 5;1(5796):376–376. doi: 10.1136/bmj.1.5796.376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eddy J. D., O'Brien E. T., Singh S. P. Glucagon and haemodynamics of acute myocardial infarction. Br Med J. 1969 Dec 13;4(5684):663–665. doi: 10.1136/bmj.4.5684.663. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Glick G., Parmley W. W., Wechsler A. S., Sonnenblick E. H. Glucagon. Its enhancement of cardiac performance in the cat and dog and persistence of its inotropic action despite beta-receptor blockade with propranolol. Circ Res. 1968 Jun;22(6):789–799. doi: 10.1161/01.res.22.6.789. [DOI] [PubMed] [Google Scholar]
- Goldstein R. E., Skelton C. L., Levey G. S., Glancy D. L., Beiser G. D., Epstein S. E. Effects of chronic heart failure on the capacity of glucagon to enhance contractility and adenyl cyclase activity of human papillary muscles. Circulation. 1971 Oct;44(4):638–648. doi: 10.1161/01.cir.44.4.638. [DOI] [PubMed] [Google Scholar]
- Greenberg B. H., Tsakiris A. G., Moffitt E. A., Frye R. L. The hemodynamic and metabolic effects of glucagon in patients with chronic valvular heart disease. Mayo Clin Proc. 1970 Feb;45(2):132–139. [PubMed] [Google Scholar]
- Hamer J., Fleming J. Action of propranolol on left ventriclar contraction in aortic stenosis when a fall in heart rate is prevented by atropine. Br Heart J. 1969 Nov;31(6):670–675. doi: 10.1136/hrt.31.6.670. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Katz R. L., Hinds L., Mills C. J. Ability of glucagon to produce cardiac stimulation without arrhythmias in halothane-anaesthetized animals. Br J Anaesth. 1969 Jul;41(7):574–578. doi: 10.1093/bja/41.7.574. [DOI] [PubMed] [Google Scholar]
- Katz R. L., Mills C. J. Use of a catheter tip electromagnetic velocity meter to determine the cardiovascular effects of glucagon. Cardiovasc Res. 1971 Jan;5(1):62–70. doi: 10.1093/cvr/5.1.62. [DOI] [PubMed] [Google Scholar]
- LINZBACH A. J. Heart failure from the point of view of quantitative anatomy. Am J Cardiol. 1960 Mar;5:370–382. doi: 10.1016/0002-9149(60)90084-9. [DOI] [PubMed] [Google Scholar]
- Leyton R. A., Sonnenblick E. H. The ultrastructure of the failing heart. Am J Med Sci. 1969 Nov;258(5):304–327. [PubMed] [Google Scholar]
- Linhart J. W., Barold S. S., Cohen L. S., Hildner F. J., Samet P. Cardiovascular effects of glucagon in man. Am J Cardiol. 1968 Nov;22(5):706–710. doi: 10.1016/0002-9149(68)90209-9. [DOI] [PubMed] [Google Scholar]
- Murtagh J. G., Binnion P. F., Lal S., Hutchison K. J., Fletcher E. Haemodynamic effects of glucagon. Br Heart J. 1970 May;32(3):307–315. doi: 10.1136/hrt.32.3.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nord H. J., Fontanes A. L., Williams J. F., Jr Treatment of congestive heart failure with glucagon. Ann Intern Med. 1970 May;72(5):649–653. doi: 10.7326/0003-4819-72-5-649. [DOI] [PubMed] [Google Scholar]
- Ross G. Regional circulatory effects of pancreatic glucagon. Br J Pharmacol. 1970 Apr;38(4):735–742. doi: 10.1111/j.1476-5381.1970.tb09882.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SARNOFF S. J., BRAUNWALD E., WELCH G. H., Jr, CASE R. B., STAINSBY W. N., MACRUZ R. Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index. Am J Physiol. 1958 Jan;192(1):148–156. doi: 10.1152/ajplegacy.1957.192.1.148. [DOI] [PubMed] [Google Scholar]
- Shinebourne E., Fleming J., Hamer J. Calibration of indicator dilution curves in man by the dynamic method. Br Heart J. 1967 Nov;29(6):920–925. doi: 10.1136/hrt.29.6.920. [DOI] [PMC free article] [PubMed] [Google Scholar]
